Nutex Health Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line

Nutex Health (NASDAQ:NUTX) Full Year 2022 Results

Key Financial Results

• Revenue: US$219.3m (down 34% from FY 2021).
• Net loss: US$424.8m (down by 420% from US$132.6m profit in FY 2021).
• US$0.67 loss per share (down from US$0.22 profit in FY 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nutex Health Earnings Insights

Looking ahead, revenue is forecast to grow 32% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Healthcare Services industry in the US.

Performance of the American Healthcare Services industry.

The company's shares are up 3.2% from a week ago.

Risk Analysis

Be aware that Nutex Health is showing 1 warning sign in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.